We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Mallinckrodt announced a $30 million settlement with two Ohio counties alleging its subsidiary, SpecGx, had a hand in the nation’s opioid crisis. Read More
A federal appeals court upheld a lower court ruling that Phigenix lacked evidence to prove a patent infringement case against Genentech for the breast cancer drug Kadcyla (ado-trastuzumab emtansine). Read More
Calls for the nomination of acting FDA Commissioner Ned Sharpless to fill the permanent leadership role at the agency continue to grow as the cutoff date for his acting status approaches. Read More
The drug was approved in March for use in combination with carboplatin and etoposide as a first-line treatment for adult patients with extensive-stage small cell lung cancer. Read More